Related Experiment Videos
Summary
Immune Augmentation Therapy (IAT) poses significant dangers to patients and offers no proven benefit for cancer treatment. Medical professionals must recognize the severe risks, including life-threatening infections, associated with IAT administration.
Area of Science:
- Oncology
- Immunotherapy
- Medical Risk Assessment
Background:
- Immune Augmentation Therapy (IAT) has been utilized in cancer treatment.
- Concerns exist regarding the safety and efficacy of IAT.
Purpose of the Study:
- To evaluate the scientific evidence and historical data of IAT.
- To determine the safety and therapeutic value of IAT in cancer care.
Main Methods:
- Review of existing scientific evidence on IAT.
- Analysis of the historical application and outcomes of IAT.
Main Results:
- IAT is unequivocally dangerous to patients.
- IAT has demonstrated no proven value as a cancer treatment.
- Patients receiving IAT face high risks of life-threatening infections.
Conclusions:
- IAT should not be used as a cancer treatment due to its inherent dangers.
- Physicians must be informed of the severe risks associated with IAT.
- The evidence strongly indicates IAT is harmful and ineffective.